Gastrointestinal

Acute cholecystitis: diagnosis and cholecystectomy timing

Clinical Overview and When to Suspect Acute Cholecystitis

— Female, Forty, Fertile, Fat, Family history

— Rapid weight loss, bariatric surgery, TPN, ceftriaxone (biliary sludge), octreotide, hemolytic disease (pigment stones), Native American/Hispanic ancestry, diabetes, cirrhosis

— Stone impacts cystic duct → gallbladder distension → mucosal ischemia → secondary bacterial invasion (E. coli, Klebsiella, Enterococcus, Enterobacter, anaerobes like Clostridium)

— Progression: edematous (2–4 d) → necrotizing (3–5 d) → suppurative/gangrenous (>5 d) → perforation

— RUQ pain >4–6 hours (distinguishes from self-limited biliary colic <4–6 h), worse after fatty meal, with fever, leukocytosis, nausea/vomiting

— Postprandial epigastric pain radiating to right shoulder/scapula (Kehr sign variant via phrenic irritation)

— Persistent symptoms despite analgesia in a patient with known cholelithiasis

— ICU patient, major trauma/burns, prolonged fasting/TPN, post-CABG, sepsis, HIV with CMV/Cryptosporidium, vasculitis

Board pearl: Biliary colic = transient cystic duct obstruction with pain <6 h, afebrile, normal WBC, normal LFTs. Once pain persists >6 h with fever or leukocytosis, call it acute cholecystitis and move toward imaging plus surgical consult — do not send these patients home from the ED on analgesics alone.

Definition: Acute inflammation of the gallbladder, most commonly (>90%) from cystic duct obstruction by a gallstone (calculous cholecystitis); 5–10% acalculous, typically in critically ill, fasting, or post-op patients.

Epidemiology and risk factors — the classic "5 F's" plus more:

Pathophysiology cascade:

When to suspect on Step 3:

Acalculous cholecystitis triggers (high mortality, 30%):

Tokyo Guidelines 2018 (TG18) framework: diagnosis requires (A) local inflammation signs + (B) systemic inflammation signs + (C) imaging findings — used to grade severity (mild/moderate/severe) and guide timing.

Presentation Patterns and Key History

— Steady, severe RUQ or epigastric pain lasting >4–6 hours (not colicky despite the historical "biliary colic" misnomer)

— Radiation to right shoulder or interscapular region (phrenic nerve referral)

— Nausea, vomiting, anorexia in 70–80%

— Low-grade fever (38–38.5°C); high fever suggests gangrene, empyema, or cholangitis

— Postprandial onset, especially 1–2 hours after a fatty meal (CCK-driven gallbladder contraction against an obstructed cystic duct)

— Elderly: vague malaise, anorexia, mental status change, minimal pain — may present afebrile with normal WBC; low threshold for imaging

— Diabetic: blunted symptoms, higher risk of emphysematous cholecystitis (Clostridium perfringens, gas in wall)

— Post-op/ICU: unexplained fever, sepsis, rising bilirubin — think acalculous

— Immunocompromised/HIV: consider CMV, Cryptosporidium, microsporidia

— Duration of current pain (>6 h is the threshold) and prior similar episodes (suggests stones)

— Fatty food trigger, weight loss history, family history of gallstones

— Medications: ceftriaxone, octreotide, OCPs, fibrates, GLP-1 agonists (rapid weight loss → stones)

— Pregnancy status, prior bariatric surgery, sickle cell disease, cirrhosis, TPN

— Jaundice or dark urine — raises concern for choledocholithiasis or Mirizzi syndrome

— Recent ERCP or biliary instrumentation

— Rigors and jaundice (Charcot triad → cholangitis)

— Severe back pain (pancreatitis from a passing stone)

— Diffuse peritonitis (perforation)

— Hematemesis or melena (rule out PUD)

Key distinction: Cholecystitis pain is constant for hours, fever and leukocytosis are present, and Murphy sign is positive. Biliary colic resolves within hours, no fever, no leukocytosis, no Murphy sign. Step 3 stems often hinge on this temporal/inflammatory distinction.

Classic symptom cluster:

Atypical presentations (test favorites):

Key history points to elicit:

Red flags suggesting complication or alternative dx:

Physical Exam Findings and Hemodynamic Assessment

— Low-grade fever typical; tachycardia common; hypotension suggests sepsis, gangrene, or perforation — escalate immediately

— In elderly/diabetic, normal vitals do not exclude advanced disease

— Murphy sign: examiner's fingers under right costal margin during deep inspiration → patient arrests inspiration due to pain. Sensitivity ~65%, specificity ~87%; less reliable in elderly

— Sonographic Murphy sign: maximal tenderness directly over the ultrasound-visualized gallbladder — higher PPV than clinical Murphy when combined with stones

— RUQ guarding, voluntary rigidity; palpable tender gallbladder in ~30% (Courvoisier sign — palpable, non-tender gallbladder with jaundice — suggests pancreatic head malignancy, not stones)

— Mild jaundice (15%) — if pronounced, suspect choledocholithiasis, Mirizzi, or cholangitis

— Rebound and rigidity → consider perforation or generalized peritonitis

— Boas sign: hyperesthesia below right scapula (classic but insensitive)

— Assess for signs of cirrhosis (raises operative risk), volume status, comorbid cardiopulmonary disease (Tokyo grade III)

— Grade I (mild): healthy patient, mild inflammation, no organ dysfunction

— Grade II (moderate): WBC >18,000, palpable tender RUQ mass, symptoms >72 h, marked local inflammation (gangrene, abscess, emphysematous, biliary peritonitis)

— Grade III (severe): any organ dysfunction — cardiovascular (vasopressors), neurologic (decreased LOC), respiratory (PaO2/FiO2 <300), renal (Cr >2 or oliguria), hepatic (INR >1.5), hematologic (plt <100k)

Step 3 management: A hypotensive, tachycardic patient with RUQ pain and fever is Tokyo Grade III — start fluids and piperacillin-tazobactam immediately, consult surgery and IR, and consider percutaneous cholecystostomy rather than emergent operation in the unstable patient.

Vital signs:

Abdominal exam:

Systemic exam:

Tokyo Guidelines 2018 severity grading — memorize:

Hemodynamic workup if unstable: lactate, ABG, blood cultures × 2, IV access, fluid resuscitation, broad-spectrum antibiotics, urgent imaging.

Diagnostic Workup — Initial Labs and Imaging

— CBC: leukocytosis 12,000–15,000 with left shift; WBC >18,000 suggests gangrene/perforation

— CMP: mild AST/ALT and alk phos elevation common from inflammation; bilirubin usually <4 mg/dL

— Bilirubin >4 mg/dL or markedly elevated alk phos → suspect choledocholithiasis, Mirizzi syndrome, or cholangitis — get MRCP/EUS

— Lipase/amylase: rule out gallstone pancreatitis

— Lactate, blood cultures × 2 if febrile/septic

— Coags, type and screen (pre-op)

— β-hCG in reproductive-age women (pregnancy + imaging choice + surgical planning)

— CRP often elevated; useful in TG18 moderate-grade criteria

— Sensitivity 81%, specificity 83%; widely available, no radiation, ideal in pregnancy

— Diagnostic findings: gallstones (cholelithiasis), gallbladder wall thickening >3–4 mm, pericholecystic fluid, sonographic Murphy sign, gallbladder distension (>4 cm transverse, >8 cm longitudinal), sludge

— Combination of stones + sonographic Murphy + wall thickening has PPV >90%

— Detects perforation, abscess, emphysematous cholecystitis (gas in wall — surgical emergency), gangrene (wall striation, absent enhancement), and alternative diagnoses

— Less sensitive for stones (only ~75% are radiopaque)

— In any patient >40 or with cardiac risk factors presenting with epigastric/RUQ pain to rule out inferior MI, which can masquerade as biliary disease — a Step 3 favorite trap

CCS pearl: On a CCS case of suspected cholecystitis, your opening order set should be: NPO, IV fluids (LR), IV opioid analgesia (morphine or hydromorphone), antiemetic, CBC, CMP, lipase, coags, type and screen, β-hCG, blood cultures if febrile, ECG, RUQ ultrasound, and surgical consult — all within the first 1–2 simulated hours.

Laboratory studies (order all initially):

First-line imaging — RUQ ultrasound:

CT abdomen/pelvis with contrast (when US equivocal or to evaluate complications):

ECG:

Diagnostic Workup — Advanced or Confirmatory Studies

— Sensitivity 96%, specificity 90%

— Tc-99m HIDA secreted into bile; non-visualization of the gallbladder at 60 minutes (or after morphine augmentation) = cystic duct obstruction = acute cholecystitis

— False positives: prolonged fasting, TPN, severe liver disease, recent meal

— Useful particularly for acalculous cholecystitis (no stones on US) — look for impaired gallbladder ejection fraction (<35%) after CCK

— When choledocholithiasis suspected (CBD >6 mm, bilirubin >4, or stones seen in CBD on US)

— Non-invasive, no radiation; ideal in pregnancy after US

— Most sensitive for small CBD stones and microlithiasis; used when MRCP equivocal and clinical suspicion high

— Therapeutic, not purely diagnostic — reserve for confirmed/highly likely choledocholithiasis or cholangitis (stone extraction, sphincterotomy, stent)

— Performed before cholecystectomy if CBD stones present

— Selective use during cholecystectomy when intermediate risk of CBD stones

— A. Local signs: Murphy sign, RUQ mass/pain/tenderness

— B. Systemic signs: fever, elevated CRP, leukocytosis

— C. Imaging: findings characteristic of acute cholecystitis

— Suspected: one A + one B; Definite: one A + one B + C

— High risk (CBD stone on US, bili >4, cholangitis): proceed to ERCP first

— Intermediate risk (bili 1.8–4, CBD 6–8 mm, age >55, abnormal LFTs): MRCP or EUS first

— Low risk: proceed to lap chole with IOC

Board pearl: A non-visualizing HIDA scan after morphine augmentation in a patient with negative ultrasound but persistent symptoms clinches the diagnosis of acute cholecystitis — and is the classic test answer when US is "unremarkable."

HIDA scan (cholescintigraphy) — the gold standard when US is equivocal:

MRCP:

Endoscopic ultrasound (EUS):

ERCP:

Intraoperative cholangiography (IOC) or laparoscopic US:

Tokyo Guidelines 2018 diagnostic criteria (must know):

Predicting CBD stones (ASGE risk stratification):

Risk Stratification and First-Line Management Logic

— NPO, IV isotonic fluids (LR preferred), IV analgesia, antiemetics, correct electrolytes, VTE prophylaxis

— IV antibiotics covering enteric Gram-negatives and anaerobes

— Surgical consultation for early laparoscopic cholecystectomy

— Early laparoscopic cholecystectomy (within 72 hours, ideally <24 h of presentation) is preferred for Tokyo Grade I and most Grade II

— Compared with delayed/interval cholecystectomy (6–8 weeks later), early surgery reduces: hospital length of stay, total cost, recurrent biliary events during the waiting period (15–30% recurrence), and overall morbidity — without increasing conversion or bile duct injury rates (level 1 evidence)

— Symptom duration >72 h is not an absolute contraindication; outcomes still favor early surgery in experienced hands

— Grade I (mild): early lap chole within 7 days, ideally <72 h

— Grade II (moderate): early lap chole at center with expertise; if unsuitable, antibiotics + percutaneous cholecystostomy, then interval chole 6–8 weeks

— Grade III (severe): organ support, broad-spectrum antibiotics, percutaneous cholecystostomy as bridge; cholecystectomy after recovery (typically 6+ weeks) once organ dysfunction resolves

— Percutaneous cholecystostomy under IR guidance, drain in place 4–6 weeks

— Subsequent elective cholecystectomy if condition permits; otherwise drain removal after cholangiogram shows patent cystic duct

Step 3 management: The single highest-yield decision point is early lap chole within 72 hours for uncomplicated acute cholecystitis. "Cool off with antibiotics and bring back in 6 weeks" is the wrong answer in a stable patient — that approach is reserved for unfit/Grade III patients or failed initial source control.

Step 3 algorithm once diagnosis is confirmed:

Timing of cholecystectomy — the central Step 3 teaching point:

Tokyo Guidelines management by grade:

Patients unfit for surgery (high cardiac/pulmonary risk, cirrhosis Child C):

Conversion-to-open factors: male sex, obesity, prior upper abdominal surgery, severe inflammation, gangrene, anatomic variation.

Pharmacotherapy — Antibiotics and Supportive Drug Regimen

— Grade I (community-acquired, mild):

— Cefazolin, cefuroxime, or ceftriaxone monotherapy

— Alternative: ampicillin-sulbactam (rising E. coli resistance — check local antibiogram)

— Grade II (moderate, community-acquired):

— Piperacillin-tazobactam, or ceftriaxone + metronidazole, or a fluoroquinolone (cipro/levo) + metronidazole in PCN allergy

— Grade III (severe) or healthcare-associated:

— Piperacillin-tazobactam, cefepime + metronidazole, or carbapenem (meropenem/imipenem) — broaden to cover Pseudomonas, ESBL, Enterococcus

— Add vancomycin if healthcare-associated or MRSA risk; consider antifungal (fluconazole/echinocandin) if Candida grows or persistent sepsis

— Post-cholecystectomy with adequate source control: 24 hours of post-op antibiotics suffice (or none) for Grade I–II

— Without source control (e.g., cholecystostomy only) or with perforation/abscess: continue 4–7 days after source control, longer if bacteremia/cholangitis

— Transition to oral (amox-clav, cipro + metronidazole) once afebrile and tolerating PO

— IV opioids (morphine, hydromorphone, fentanyl) — historical concern about morphine causing sphincter of Oddi spasm is clinically insignificant; do not withhold

— Avoid NSAIDs if renal dysfunction or pre-op bleeding concern, though ketorolac is acceptable in many cases

Board pearl: Ceftriaxone has paradoxically been implicated in biliary sludge and pseudolithiasis (especially in children/prolonged use) — but it remains first-line empiric therapy for mild community-acquired cholecystitis. Don't be confused by this dual identity on test stems.

Empiric antibiotic selection (Tokyo Guidelines 2018 + IDSA):

Anaerobic coverage: routinely add metronidazole when using ceftriaxone or cefepime; pip-tazo and carbapenems already cover anaerobes

Duration of antibiotics:

Analgesia:

Adjuncts: ondansetron for nausea, IV PPI if NPO and stressed, VTE prophylaxis (LMWH or heparin), correct K/Mg.

Procedures — Laparoscopic Cholecystectomy and Alternatives

— 4-port technique; critical view of safety (CVS) must be achieved: hepatocystic triangle cleared of fat/fibrous tissue, lower third of gallbladder separated from liver, only two structures (cystic duct and cystic artery) entering the gallbladder

— Intraoperative cholangiography selective; mandatory if anatomy unclear or CBD stone suspected

— Conversion to open in 5–10% (higher with gangrene, severe inflammation, prior surgery)

— Early (<72 h, ideally <24 h): preferred for stable patients regardless of symptom duration

— Delayed/interval (6–8 weeks): only if patient unfit, source control achieved with cholecystostomy, or local expertise lacking

— During the "waiting" interval, 15–30% develop recurrent biliary events (recurrent cholecystitis, pancreatitis, CBD stones)

— Bailout when CVS unattainable due to severe inflammation; leaves a remnant cuff to avoid bile duct injury

— Lower bile duct injury rate but small risk of recurrent stones in remnant

— IR-placed transhepatic drain; preferred in unfit/Grade III patients, critically ill ICU acalculous cholecystitis

— Improves sepsis within 48–72 h in ~85%; maintain drain 4–6 weeks until cholangiogram shows patent cystic duct

— Definitive cholecystectomy still preferred later if patient becomes fit (recurrence ~35% without interval chole)

— Emerging alternative at expert centers, especially for high-risk surgical candidates

— When choledocholithiasis or cholangitis present — clear duct endoscopically, then proceed to LC during same admission

CCS pearl: When you order "surgery consult" in CCS for acute cholecystitis, also advance the clock and order pre-op labs (type and screen, coags, ECG), informed consent documentation, NPO status, and continued antibiotics — the case rewards integrated perioperative thinking, not just the diagnosis.

Laparoscopic cholecystectomy (LC) — gold standard:

Timing review — the key Step 3 fact:

Subtotal cholecystectomy (fenestrating or reconstituting):

Percutaneous cholecystostomy (PC):

Endoscopic gallbladder drainage (EUS-GBD or transpapillary):

ERCP first, then LC:

Special Populations — Elderly and Renal/Hepatic Impairment

— Atypical, blunted presentation — afebrile, normal WBC in up to 30%; rely on imaging and clinical gestalt

— Higher rates of gangrene, perforation, empyema, and emphysematous cholecystitis

— Mortality from acute cholecystitis rises sharply >70 years (5–10%), and dramatically with delay

— Early lap chole still favored when fit; data show better outcomes than non-operative management even in octogenarians

— Assess frailty (Clinical Frailty Scale), cognitive baseline, cardiac/pulmonary reserve; multidisciplinary perioperative optimization

— If truly unfit: percutaneous cholecystostomy with planned interval surgery or definitive drain management

— Child-Pugh A: lap chole feasible with experienced surgeon; expect more bleeding

— Child-Pugh B: high-risk; consider cholecystostomy as bridge

— Child-Pugh C: cholecystectomy carries 25%+ mortality — percutaneous cholecystostomy preferred, definitive surgery only with transplant evaluation

— MELD >15 strongly predicts post-op complications

— Adjust antibiotics: cefazolin (reduce dose), pip-tazo (renal dosing), avoid nephrotoxins

— Higher infection and bleeding risk; uremic platelet dysfunction — consider DDAVP perioperatively

— Avoid NSAIDs; cautious contrast use (US and HIDA preferred over CT)

— Higher risk of emphysematous cholecystitis (Clostridium perfringens, E. coli) — gas in gallbladder wall on imaging — surgical emergency

— Worse outcomes overall; tight glycemic control perioperatively (target 140–180 mg/dL)

— Lower threshold for imaging and intervention; atypical pathogens (CMV, Cryptosporidium) in acalculous disease

— Broader empiric antibiotics, fungal coverage if persistent sepsis.

Key distinction: A diabetic elderly patient with RUQ pain, sepsis, and gas in the gallbladder wall on CT has emphysematous cholecystitis, not routine cholecystitis — requires urgent cholecystectomy (not delayed cooling-off) and broad anaerobic coverage including clostridial species.

Elderly (>65–75):

Cirrhosis:

Chronic kidney disease/dialysis:

Diabetes mellitus:

Immunocompromised (transplant, chemo, HIV):

Special Populations — Pregnancy, Pediatrics, Bariatric

— Second most common non-obstetric surgical emergency after appendicitis

— Rising estrogen → cholesterol supersaturation; progesterone → impaired gallbladder emptying

— RUQ ultrasound is first-line — safe, sensitive

— MRCP without gadolinium is safe in 2nd/3rd trimesters when needed

— Laparoscopic cholecystectomy is safe in any trimester, but 2nd trimester is ideal (organogenesis complete, uterus not yet obstructing field)

— Non-operative management is associated with high recurrence (40–70%) and increased preterm labor and fetal loss — so operate, don't temporize, especially for recurrent symptoms

— Maintain left lateral tilt intraop after 20 weeks; lower insufflation pressures (10–12 mmHg); fetal monitoring per gestational age

— Less common; consider hemolytic disease (sickle cell, hereditary spherocytosis → pigment stones), TPN, obesity, CF

— Adolescent girls on OCPs with obesity — increasing incidence

— Lap chole is standard; in sickle cell, perform during well state with exchange transfusion if needed; transfuse to Hb ~10 pre-op

— Rapid weight loss → cholesterol stone formation in up to 30% within 6 months post-RYGB or sleeve

— Prophylactic ursodeoxycholic acid 300 mg BID × 6 months reduces stone formation by ~70%

— Routine prophylactic cholecystectomy at time of bariatric surgery is not recommended unless symptomatic stones present

— Pigment stones common; once symptomatic, elective cholecystectomy recommended due to high recurrence and risk of confusing biliary pain with vaso-occlusive crisis

Step 3 management: A 28-year-old at 22 weeks gestation with RUQ pain, fever, stones, and a thickened gallbladder on US — answer is laparoscopic cholecystectomy now (during the second trimester), not "antibiotics and delay until postpartum." Delay leads to recurrence, fetal complications, and emergent surgery under worse conditions.

Pregnancy:

Pediatrics:

Post-bariatric surgery:

Sickle cell disease:

Complications and Adverse Outcomes

— Gangrenous cholecystitis (20%): wall ischemia, necrosis; higher WBC (>17,000), CRP, age >50, diabetes; mortality 15–50%; needs urgent surgery

— Gallbladder perforation (5–10%):

— Type I: free perforation → bile peritonitis, high mortality

— Type II: localized perforation → pericholecystic abscess

— Type III: chronic perforation → cholecystoenteric fistula

— Emphysematous cholecystitis: gas in wall/lumen; Clostridium, E. coli, Klebsiella; diabetic men; mortality 15%; emergent surgery

— Empyema of gallbladder: pus-filled, septic; needs urgent decompression

— Mirizzi syndrome: stone in cystic duct compresses CBD → obstructive jaundice; risk of bile duct injury at surgery

— Cholecystoenteric fistula → gallstone ileus: stone erodes into duodenum, lodges at ileocecal valve; Rigler triad on imaging: pneumobilia + small bowel obstruction + ectopic gallstone

— Bouveret syndrome: stone impacts in duodenum → gastric outlet obstruction

— Ascending cholangitis if CBD also obstructed (Charcot triad, Reynolds pentad)

— Gallstone pancreatitis from concurrent CBD stone passage

— Porcelain gallbladder (chronic): calcified wall, premalignant — cholecystectomy indicated

— Bile duct injury (0.3–0.6% of LC): most feared; misidentification of CBD as cystic duct; requires hepatobiliary referral, often hepaticojejunostomy

— Retained CBD stones (post-op ERCP)

— Bile leak from cystic duct stump or duct of Luschka — drain, ERCP with stent

— Hemorrhage, infection, port-site hernia, retained gallstones in peritoneum

— Post-cholecystectomy syndrome: persistent symptoms in 5–10% — workup for sphincter of Oddi dysfunction, retained stones, functional dyspepsia.

Board pearl: Pneumobilia + small bowel obstruction + an ectopic gallstone on imaging = gallstone ileus (Rigler triad). Treatment is enterolithotomy to relieve obstruction; cholecystectomy and fistula repair are usually deferred or omitted in frail patients.

Disease-related complications (rising severity):

Surgical complications:

When to Escalate Care — ICU, Consults, and Triage

— Goal: early lap chole within 72 h

— Document time of consult; track in CCS

— Hypotension requiring vasopressors

— Altered mental status, GCS drop

— PaO2/FiO2 <300, mechanical ventilation

— Cr >2 mg/dL, oliguria, or rising lactate

— INR >1.5, platelets <100k

— Severe sepsis/septic shock — Surviving Sepsis bundle: fluids 30 mL/kg LR, lactate, blood cultures, broad-spectrum antibiotics within 1 hour, vasopressors (norepinephrine) for MAP <65

— For percutaneous cholecystostomy in unfit/Grade III patients

— Drainage of pericholecystic abscess if not amenable to surgical drainage

— For ERCP when choledocholithiasis or cholangitis present

— EUS for indeterminate CBD evaluation

— Cardiac risk stratification (RCRI, ACS NSQIP); echo or stress testing only if it would change management — avoid routine pre-op cardiac testing for low-risk patients

— Optimize glycemic control, anticoagulation bridging plan (hold warfarin, bridge if high-risk valve or AF with CHA2DS2-VASc ≥7, hold DOACs 48 h pre-op for normal renal function)

— Cirrhosis Child B/C — assess MELD, decide on cholecystostomy vs. surgery, transplant candidacy

— All confirmed acute cholecystitis patients warrant admission — no outpatient management

— Floor admission for stable Grade I; step-down for Grade II; ICU for Grade III

— Suspected bile duct injury, complex Mirizzi, Child C cirrhosis with cholecystitis, or lack of local ERCP/IR capability.

CCS pearl: In CCS, advancing the clock without obtaining surgical consultation or imaging is a deduction. Order surgery consult immediately on arrival, even before final imaging — it parallels real-world parallel processing and gets the operative pathway moving.

Surgical consultation — mandatory in every confirmed case:

ICU admission criteria (Tokyo Grade III):

Interventional radiology consult:

GI consult:

Anesthesia/medicine pre-op consult:

Hepatology consult:

Inpatient triage:

Transfer to tertiary center:

Key Differentials — Same-Category (Hepatobiliary/Pancreatic) Causes

— Pain <4–6 h, postprandial, no fever, normal WBC and LFTs, normal US wall thickness; treat with elective lap chole if symptomatic

— Stone in CBD; jaundice, markedly elevated bilirubin (>4) and alk phos, dilated CBD (>6 mm) on US; no gallbladder inflammation; treat with ERCP then LC

— Charcot triad (fever, RUQ pain, jaundice) + hypotension + altered mental status (Reynolds pentad); CBD obstruction with infection; emergent IV antibiotics + urgent biliary decompression via ERCP within 24–48 h

— Epigastric pain radiating to back, lipase >3× ULN, transient ALT spike (>150 has high PPV); treat supportively, ERCP if cholangitis or persistent obstruction, lap chole during same admission once mild pancreatitis resolves

— Diffuse hepatocellular injury, AST/ALT in thousands (viral) or AST:ALT >2:1 with both <500 (alcoholic); systemic symptoms; normal gallbladder on US

— Fever, RUQ pain, weight loss; hypodense liver lesion on CT/US; aspirate and drain, IV antibiotics ± metronidazole for amebic

— Tender hepatomegaly, edema, elevated JVP; US Doppler abnormalities

— Post-cholecystectomy biliary-type pain with elevated LFTs; manometry diagnostic

— Same syndrome without stones; ICU patients, TPN, post-op; HIDA confirms

— Older patient, weight loss, mass on US; consider with porcelain gallbladder, polyps >1 cm, or PSC.

Key distinction: Bilirubin >4 + dilated CBD moves you out of "isolated cholecystitis" into choledocholithiasis ± cholangitis — order MRCP or proceed to ERCP, and treat the duct before (or simultaneously with) the gallbladder. Missing this on Step 3 is a classic loss point.

Biliary colic (uncomplicated cholelithiasis):

Choledocholithiasis:

Ascending cholangitis:

Gallstone pancreatitis:

Acute hepatitis (viral, alcoholic, drug-induced):

Liver abscess (pyogenic or amebic):

Hepatic congestion (right heart failure, Budd-Chiari):

Sphincter of Oddi dysfunction:

Acalculous cholecystitis:

Gallbladder malignancy:

Key Differentials — Other-Category Causes

— Inferior wall MI — referred epigastric/RUQ pain, nausea, vomiting; always get an ECG in patients >40 or with cardiac risk factors presenting with upper abdominal pain

— Pericarditis, aortic dissection (especially with back/abdominal pain) — check BP in both arms, consider CTA

— Right lower lobe pneumonia → pleuritic pain referred to RUQ; CXR diagnostic

— Pulmonary embolism — pleuritic pain, hypoxia, tachycardia

— Perforated peptic ulcer: sudden severe epigastric pain, peritoneal signs, free air under diaphragm on upright CXR

— Acute pancreatitis (any cause): epigastric → back pain, elevated lipase

— Appendicitis: especially with retrocecal or pregnant patient (displaced upward) — can mimic RUQ pain

— Bowel obstruction or ischemia: pain out of proportion, lactic acidosis

— Gastritis, GERD, gastroparesis, functional dyspepsia

— Hepatic flexure colitis or diverticulitis

— Right pyelonephritis: fever, CVA tenderness, pyuria

— Right ureterolithiasis: colicky flank pain radiating to groin, hematuria, CT stone

— Ectopic pregnancy (always β-hCG)

— Right ovarian torsion, ruptured ovarian cyst

— Pelvic inflammatory disease with Fitz-Hugh-Curtis syndrome — perihepatitis from Chlamydia/Gonorrhea, RUQ pain, "violin-string" adhesions on laparoscopy; treat the PID, not the gallbladder

— HELLP syndrome in pregnancy: RUQ pain, hemolysis, elevated LFTs, low platelets — emergent delivery

— Costochondritis, herpes zoster (T7–T9 dermatome before rash, look for vesicles)

— Adrenal hemorrhage, abdominal wall hematoma (anticoagulated patient), DKA can cause abdominal pain.

Board pearl: A young, sexually active woman with RUQ pain, normal gallbladder on US, and vaginal discharge or recent unprotected intercourse — think Fitz-Hugh-Curtis (PID perihepatitis). Treat with ceftriaxone + doxycycline (± metronidazole), not surgery.

Cardiac (don't miss):

Pulmonary:

Gastrointestinal (non-biliary):

Renal:

Gynecologic (in women):

Musculoskeletal:

Other:

Secondary Prevention, Discharge Medications, and Long-Term Plan

— Most uncomplicated LC patients discharge same day or POD 1

— Pain control: acetaminophen scheduled + short course (3–5 days) of oxycodone or hydrocodone-acetaminophen; encourage ibuprofen as opioid-sparing if no contraindications

— Antiemetic PRN (ondansetron)

— VTE prophylaxis: ambulate early; LMWH for high-risk patients

— Discontinue pre-op antibiotics — no routine post-discharge antibiotic course needed for uncomplicated LC

— Resume home medications including statins, antihypertensives; resume anticoagulation 24–48 h post-op per bleeding risk

— Low-fat diet for 2–4 weeks to minimize diarrhea/bloating (bile salts now drip continuously into duodenum)

— Avoid heavy lifting (>10 lb) × 2 weeks; resume light activity immediately

— Return to work in 1–2 weeks for lap chole; 4–6 weeks for open

— Persistent fatty food intolerance and loose stools (~10%) usually resolve over months; can try bile acid sequestrant (cholestyramine) if persistent post-cholecystectomy diarrhea

— Drain care education; output monitoring

— Plan interval cholecystectomy at 6–8 weeks if fit

— Cholangiogram before drain removal to confirm cystic duct patency

— Ursodeoxycholic acid 8–10 mg/kg/day for radiolucent cholesterol stones <1 cm with functioning gallbladder — modest efficacy, slow, high recurrence after stopping; not first-line but acceptable when surgery contraindicated

— Weight loss (gradual, <1.5 lb/week to avoid stone formation), diet rich in fiber and unsaturated fats

— Ursodeoxycholic acid 300 mg BID × 6 months prophylactically.

Step 3 management: The discharge order set after lap chole should include scheduled acetaminophen, limited opioid script with naloxone education if dose >50 MME/day, low-fat diet counseling, and a 2-week surgical follow-up appointment — bundled discharge planning is exam-tested.

Post-cholecystectomy discharge plan:

Activity and diet counseling:

Patients managed non-operatively (cholecystostomy or antibiotics only):

Recurrence prevention (no surgery candidates):

For at-risk patients (post-bariatric):

Follow-Up, Monitoring, and Counseling

— Surgical clinic visit at 2 weeks for wound check, pathology review, symptom assessment

— Primary care visit at 4–6 weeks if comorbidities require optimization

— Final pathology review — always check for incidental gallbladder cancer (1–2% incidence in cholecystectomy specimens); if found:

— T1a (mucosa only, negative margins): cholecystectomy alone sufficient

— T1b or higher: refer to hepatobiliary oncology for extended cholecystectomy (liver segments IVb/V resection + portal lymphadenectomy)

— Watch for fever, escalating pain, jaundice, drain output changes, bilious drainage from port sites (bile leak)

— Persistent or rising LFTs post-op → consider retained CBD stone or bile leak → MRCP/ERCP

— Weekly drain output and skin check

— Cholangiogram at 4–6 weeks before considering removal

— Plan interval cholecystectomy as soon as fit

— Reassure: living without a gallbladder is well tolerated; bile flows continuously into duodenum

— Expect possible transient bloating, loose stools, postprandial diarrhea; usually self-limited

— Avoid high-fat meals initially; gradually reintroduce

— Symptoms suggesting complications: fever >38°C, increasing abdominal pain, jaundice, dark urine, pale stools, persistent vomiting → return to ED

— Diabetes: continue tight glycemic control

— Obesity: counsel on gradual weight loss; refer to lifestyle programs; consider bariatric evaluation

— Hyperlipidemia: continue statins (not contraindicated post-chole)

— Cardiovascular risk factors: this admission is an opportunity to revisit BP, lipids, smoking cessation, ASCVD risk score.

CCS pearl: On a CCS case ending after cholecystectomy, advance the clock to the 2-week post-op visit, recheck LFTs if originally abnormal, review pathology, and address comorbidities — closing the loop earns points and reflects realistic transitions-of-care management.

Post-op follow-up schedule:

Wound and recovery monitoring:

Patients with cholecystostomy drain:

Counseling points:

Comorbidity optimization (Step 3 longitudinal lens):

Ethical, Legal, and Patient Safety Considerations

— Must cover risks: bleeding, infection, conversion to open (~5–10%), bile duct injury (~0.3–0.6%), retained stones, bile leak, port-site hernia, VTE, anesthesia risk, mortality (<0.5% elective, higher in emergent/elderly)

— Discuss alternatives: percutaneous cholecystostomy, antibiotics only (with high recurrence)

— Capacity assessment: delirious or septic-encephalopathic patients lack capacity — proceed with surrogate consent (durable POA, then hierarchy per state law). Document the conversation and surrogate

— Emergency exception: life-threatening perforation or septic shock in a patient who cannot consent and has no available surrogate — proceed under implied consent; document urgency

— Discuss blood product preferences in advance; use cell-saver, tranexamic acid, iron optimization; have signed advance directive on chart

— Counsel that surgery is safer than expectant management; document fetal counseling and obstetric coordination

— Wrong-site surgery prevented by WHO surgical safety checklist, time-out, site marking

— Retained surgical items: instrument and sponge counts

— Bile duct injury — universally requires intraoperative recognition or immediate post-op recognition; disclose the error to the patient (transparent disclosure is standard of care and often mandated)

— Antibiotic continuation or discontinuation must be clearly communicated; medication reconciliation at discharge prevents over-prescription

— DVT prophylaxis bridging: clear plan for resuming home anticoagulation (e.g., AF, mechanical valve) to prevent thromboembolic event in the post-op window

— Communicate pending pathology (incidental cancer) to PCP and patient

— Suspected abuse (e.g., elder presenting late, signs of neglect) — engage social work and report per state law.

Board pearl: If a Step 3 stem describes a patient discharged after lap chole on warfarin for a mechanical mitral valve with no bridging plan and they return with stroke — the answer addresses the failed transition of care, not the cholecystectomy itself. Anticipate and document anticoagulation resumption.

Informed consent:

Jehovah's Witness patient:

Pregnancy and shared decision-making:

Patient safety / Never Events:

Transitions of care risks:

Mandatory reporting (rare but possible):

High-Yield Associations and Rapid-Fire Clinical Facts

— Cholesterol stones (80%): obesity, female, OCPs, rapid weight loss, Native American

— Pigment stones: black (hemolysis, cirrhosis), brown (biliary infection/parasites, Asia, Clonorchis)

— Murphy sign — RUQ inspiratory arrest

— Boas sign — right subscapular hyperesthesia

— Courvoisier sign — palpable nontender GB + jaundice → pancreatic ca, not stones

— Charcot triad — fever, RUQ pain, jaundice (cholangitis)

— Reynolds pentad — adds hypotension and altered mental status

— Rigler triad — pneumobilia + SBO + ectopic gallstone (gallstone ileus)

— Mirizzi syndrome — cystic duct stone compressing CBD

— Bouveret syndrome — gallstone in duodenum causing gastric outlet obstruction

— Fitz-Hugh-Curtis — PID perihepatitis

— GB wall thickening >3–4 mm

— CBD upper limit: 6 mm (+1 mm per decade after 60, or up to 10 mm post-cholecystectomy)

— HIDA non-visualization at 60 min (or post-morphine) = positive

— Ceftriaxone → biliary sludge/pseudolithiasis

— Octreotide → stones

— Fibrates (gemfibrozil) → cholesterol stones

— GLP-1 agonists, OCPs, estrogen → stones

— TPN → acalculous cholecystitis

— Crohn ileitis or terminal ileal resection (bile salt malabsorption)

— Cystic fibrosis, sickle cell, hereditary spherocytosis, cirrhosis, pregnancy

— Porcelain gallbladder, polyps >1 cm, PSC, large stones (>3 cm), chronic Salmonella typhi infection

— Lap chole conversion rate: 5–10%

— Bile duct injury: 0.3–0.6%

— 30-day mortality elective: <0.5%; emergent in elderly: 5–10%.

Step 3 management: A patient with porcelain gallbladder found incidentally on imaging — recommend prophylactic cholecystectomy due to gallbladder cancer risk (~2–7%), even when asymptomatic.

Stone composition:

Signs and eponyms:

Imaging numbers to memorize:

Microbiology: E. coli > Klebsiella > Enterococcus > Enterobacter > anaerobes (Bacteroides, Clostridium)

Drugs causing biliary issues:

Conditions linked to gallstones:

Cancer risk:

Procedure benchmarks:

Board Question Stem Patterns

— 45F obese with RUQ pain x 8 hours, fever 38.3°C, WBC 14k, sonographic Murphy with wall thickening 5 mm and stones

— Answer: Admit, IV antibiotics, early laparoscopic cholecystectomy within 72 hours. Distractor: "delayed cholecystectomy in 6 weeks" — wrong for stable patients

— Symptoms classic, US shows stones but no wall thickening or sonographic Murphy

— Answer: HIDA scan to confirm cystic duct obstruction

— RUQ pain, fever, bilirubin 6, alk phos 400, CBD 10 mm on US

— Answer: ERCP first (for likely choledocholithiasis), then lap chole during same admission. If frank cholangitis with shock → emergent decompression + antibiotics

— Post-op patient, day 5, fever, RUQ pain, US shows wall thickening but no stones

— Answer: Percutaneous cholecystostomy (and broad-spectrum antibiotics)

— 24-week pregnant woman with recurrent biliary colic now with acute cholecystitis

— Answer: Laparoscopic cholecystectomy in second trimester, not delay to postpartum

— Child C cirrhotic with acute cholecystitis

— Answer: Percutaneous cholecystostomy + antibiotics, surgery deferred or coordinated with transplant

— Diabetic male with sepsis, gas in GB wall on CT

— Answer: Emergent cholecystectomy + broad anaerobic coverage (pip-tazo or carbapenem)

— Elderly with SBO, pneumobilia, ectopic stone on CT

— Answer: Enterolithotomy to relieve obstruction

— POD 3 with fever, RUQ pain, bilious drain output

— Answer: ERCP with sphincterotomy and stent, percutaneous drainage of bile collection

— Answer: Elective cholecystectomy for cancer risk.

Board pearl: Whenever a stable patient with acute cholecystitis is offered "cool off with antibiotics for 6 weeks then operate," that distractor is the wrong answer unless the patient is unfit for surgery or Tokyo Grade III — early lap chole wins.

Pattern 1 — Classic uncomplicated case:

Pattern 2 — Equivocal ultrasound:

Pattern 3 — Elevated bilirubin:

Pattern 4 — Critically ill ICU acalculous:

Pattern 5 — Pregnancy:

Pattern 6 — Cirrhosis:

Pattern 7 — Emphysematous cholecystitis:

Pattern 8 — Gallstone ileus:

Pattern 9 — Post-cholecystectomy bile leak:

Pattern 10 — Incidental porcelain gallbladder:

One-Line Recap

Acute cholecystitis is RUQ pain >6 hours with fever, leukocytosis, and gallbladder inflammation on imaging — confirm with ultrasound (or HIDA if equivocal), start IV antibiotics, and perform early laparoscopic cholecystectomy within 72 hours, reserving percutaneous cholecystostomy for patients too unfit for surgery.

— Persistent RUQ pain + fever + leukocytosis + sonographic Murphy/wall thickening/pericholecystic fluid + stones

— HIDA scan (non-visualization) confirms when US equivocal; suspect choledocholithiasis if bili >4 or CBD >6 mm and pursue MRCP/ERCP

— Apply Tokyo Guidelines 2018 to grade severity (I mild, II moderate, III severe with organ dysfunction)

— NPO, IV fluids, analgesia, antiemetics, empiric antibiotics (cefazolin for mild; pip-tazo or carbapenem for severe/healthcare-associated)

— Early laparoscopic cholecystectomy within 72 hours is the gold standard for stable patients — same-admission, not interval

— Percutaneous cholecystostomy as bridge for Tokyo Grade III, Child C cirrhosis, ICU acalculous cholecystitis, or otherwise unfit patients

— In pregnancy, operate (preferably 2nd trimester) rather than temporize

— ERCP first if choledocholithiasis or cholangitis present, then LC same admission

— Always check pathology for incidental gallbladder cancer (1–2%)

— Bile duct injury (0.3–0.6%) requires immediate recognition and disclosure

— 2-week post-op surgical follow-up; counsel on low-fat diet, expected transient diarrhea, return precautions for fever/jaundice/pain

— Prophylactic cholecystectomy for porcelain gallbladder, polyps >1 cm, or chronic Salmonella carriers

Step 3 management: Early lap chole within 72 hours beats delayed surgery on every metric — make it your default answer for stable acute cholecystitis.

Diagnosis recap:

Management recap:

High-yield safety/follow-up:

Don't-miss differentials: inferior MI (get ECG), perforated PUD (free air), gallstone pancreatitis (lipase), cholangitis (Charcot triad), Fitz-Hugh-Curtis in young women, gallstone ileus (Rigler triad in elderly with SBO).